Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HOWL - Jazz Pharmaceuticals: Strong Launch Of Xywav In Idiopathic Hypersomnia

HOWL - Jazz Pharmaceuticals: Strong Launch Of Xywav In Idiopathic Hypersomnia

Werewolf Therapeutics Inc.
  • Jazz Pharmaceuticals missed first quarter revenue estimates, but management raised the full-year guidance.
  • The launch of Xywav in idiopathic hypersomnia looks strong, and has driven the best quarter for the oxybate franchise since mid-2020.
  • Business development activity picked up with two in-licensing deals and the sale of Sunosi to Axsome Therapeutics.
  • Jazz is executing well against its long-term goals.

For further details see:

Jazz Pharmaceuticals: Strong Launch Of Xywav In Idiopathic Hypersomnia
Stock Information
Company Name: Werewolf Therapeutics Inc.
Stock Symbol: HOWL
Market: NASDAQ
Website: werewolftx.com
Menu
HOWL HOWL Quote HOWL Short HOWL News HOWL Articles HOWL Message Board
Get HOWL Alerts

News, Short Squeeze, Breakout and More Instantly...